| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | -2,1 M € | -14.8% | -1,8 M € | -58.3% | -1,1 M € | -301.9% | -281,2 k € | +64.2% | -785,4 k € | +0.9% | -792,6 k € | |
| EBITDA | -3,2 M € | -18.0% | -2,7 M € | -44.7% | -1,9 M € | -247.9% | -535,4 k € | +60.9% | -1,4 M € | -47.6% | -929,1 k € | |
| Operating profit | -3,2 M € | -17.9% | -2,7 M € | -44.4% | -1,9 M € | -248.2% | -538,7 k € | +61.0% | -1,4 M € | -48.0% | -932,1 k € | |
| Profit/loss | -3,4 M € | -20.5% | -2,8 M € | -47.7% | -1,9 M € | -249.8% | -547,0 k € | +60.6% | -1,4 M € | -48.6% | -933,1 k € | |
| Equity | -7,7 M € | -78.5% | -4,3 M € | -187.3% | -1,5 M € | -474.0% | 403,6 k € | +261.9% | -249,4 k € | -253.7% | 162,2 k € | |
| Total assets | 732,2 k € | +34.4% | 544,6 k € | -76.7% | 2,3 M € | +15.7% | 2,0 M € | +815.4% | 221,0 k € | -28.5% | 309,1 k € | |
| Cash | 241,9 k € | +283.1% | 63,1 k € | -96.8% | 2,0 M € | +2.4% | 1,9 M € | +1183.2% | 149,2 k € | -40.2% | 249,6 k € | |
| Debts | 8,5 M € | +73.6% | 4,9 M € | +26.8% | 3,8 M € | +138.0% | 1,6 M € | +243.9% | 470,4 k € | +220.3% | 146,9 k € | |
| Staff | 12,7 | 11,2 | 9,3 | 8,2 | — | — | ||||||
Private limited company · Diepenbeek · incorporated on 06/02/2019 · 12,7 ETP
Private limited company loss-making in the latest fiscal year. Cash position rising (+283.1%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
BIOSTRAND is a Private limited company incorporated in 2019. Its main activity is: Recherche-développement en biotechnologie. Its registered office is in Diepenbeek. It employs on average 12,7 ETP workers (FTE).
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette